News & Analysis on Clinical Trial Services & Contract Research And Development
ABPI, Mike Thompson
By Maggie Lynch
- Last updated on
Mike Thompson the chief executive of the Association of The British Pharmaceutical Industry (ABPI) announced that he will be retiring at the end of 2019.
ABPI represents pharmaceutical companies that supply more than 80% of all branded medicines used by the National Health Service, and organizations currently developing and researching current medicines pipelines.
“This has been an extraordinary period to have had led the ABPI. Whilst the media has focused on the challenges the country has faced, we can be proud of how we’ve used the dynamic to bring about positive change,” Thompson said.
He added that he made the announcement at this time to enable an open and timely process to find his successor.